Our product


Virulina is a research product by Dr Anil Sharma (Clinician & Researcher ) & Dr. Sandeep Arora(Professor & Director, Amity Institute of Pharmacy) for which patent has been granted bearing IPR No:404858

Each 2 gm of sachet contains:

Daruharidra Berberris 50mg
Solanum indicum Linn100mg
Marshdenia Tenacissima50mg
Tinospora Cordifolia100mg
Alhagi pseudalhagi50mg
Picrorhiza Kurrooa50mg
Gentian Kurroo50gm
Pavonia odorata willd50mg
Chaal Azadirachta India100mg
Glycrrhiza Glabra50mg
Holarrhena Antidysentrica100mg
Trachyspermum Ammi50mg
Clerodendrum Serratum100mg
Putranjiva Roxburghii50mg
Swertia Chireta 50mg
Acorus Calamus 50mg
Plumbago Zeylanica 50mg
Cedrus Deodara50mg
Piper Retrofractum 50mg
Trichosanthes Dioica50mg
Andrographis Paniculate100mg
Syzigium Aromaticum100mg
Nelumbo Nucifera100mg
Orchis Latifolia50mg
Cinnamomum Tamala50mg
Talispatra Taxaceae50gm
Myristica Fragranas50mg
Aconitum heterophyllum100mg
Curcuma Longa50mg
Cinnamomum Verum50mg
Chrysopogon Zizanioides50mg
Santalum Album50mg
Cida cordifolia50mg
Desmodium gangeticum 100mg
Uraria picta 100mg

Mode of Action

Virulina also, by inhibiting RNA polymerase in COVID 19 viral cells, inhibits the replication of Viral RNA. The anti viral study conducted at Regional Centre of Biotechnolofy clearly concludes that Virulina is a promising candidate for treatment in covid-19 as it has has shown 95.9% inhibition activity visa vis 98.6% of remdesivir on wuhan corona virus strain.VIRULINA in preclinical studies, also enhances the phagocytic efficacy of the PMN cells against infecting microbial cells, thereby stimulating a non-specific immune response.

VIRULINA has shown by preclinical studies, an increase in the early and delayed hypersensitivity reaction to immunogenicity induciers and has a stimulatory effect on chemotaxis dependent leucocyte migration and Proliferation of Lymphocyte, establishing it as an immuno-modulator. VIRULINA in preclinical studies, also enhances the phagocytic efficacy of the PMN cells against infecting microbial cells, thereby stimulating a non-specific immune response.

VIRULINA may alleviate poly(I:C)-induced inflammation by decreasing levels of inflammatory mediators, such as Nitric Oxide, cytokines, chemokines, and growth factors, in RAW 264.7 mouse macrophages and is thus a candidate for modulating virus-hyperinflammation such as a cytokine storm, in COVID 19 infections, and has a significant mucolytic and fibrinolytic activity.

In vitro studies states that Virulina® Proliferates T-Lymphocyte which triggers antibody producing T-Cell, Beta cells and Antigen cells




Valuable Documents

Anti-viral study

Anti-viral study

IP Rights

Frequently asked questions

Virulina is a poly herbal combination, A powerful immuno-stimulant which is clinically tested. As per the studies conducted it is clinically proven that it helps in prevention of life threatening symptoms such as Acute Respiratory Distress Syndrome (ARDS) caused due to Covid 19 infection. Which is one of the major cause of deaths in Covid-19.Virulina effectively treats cough, fever, shortness of breath, chest congestion, nasal congestion, Diarrhoea, Other GI symptoms, Anosmia, Ageusia, fatigue, Neuro disorders, Myalgia, sleep disorder, Rhinorrhea, helps expectoration, sore throat and vomiting.

Yes Virulina a 100% natural product which contains all natural ingredients. It does not contain any metals/ mineral which can be harmful for our health.

Dosage for virulina are as following Adults: Virulina should be given 2 gms T.I.D (Adults 18 years to 80 years) which would help and support to build up our immunity. Children: Virulina 2gms B.I.D for children’s less than 18 years as Note: In case of severity the dosage can go up to 2 gm six times a day.

Virulina probably stimulates lymphocyte proliferation, which in turn leads to production of cytokines which activate other immune cells such as B cells, antigen-presenting cells and other T cells. Product Virulina has successfully concluded In vitro study and human trials. Virulina was found to have a significant immuno-stimulant activity on both the specific and non-specific immune mechanisms.

Immunity is visible In vitro phagocytosis test: Virulina was evaluated at concentrations of 5, 10 and 20, 50 and 100mg/ml. It showed significant activity at concentrations of 100 mg/ml. As neutrophils form the first line of host defense by virtue of their phagocytic ability to engulf invading microorganisms, they have a major role in modulating the immune function. The stimulation of neutrophils results in an increase in the immediate cellular immune response. The results of the in vitro PMN function test showed a significant increase in the percentage phagocytosis and phagocytic index for successive methanol and water extracts. This indicates that VirulinaR-NS enhances the phagocytic efficacy of the PMN cells at 100 mg/ml by causing more engulfment of the Candida cells versus control, thereby stimulating a non-specific immune response.

Cough, Fever(With or Without Chill),shortness of breath, chest congestion, Nasal Congestion, Sore throat, Gastric irritable Symptoms , Fatigue, Loss of Tate & Smell anosmia, Myalgia , headache , Sleep Disorder etc. are major symptom’s which we need to address and take care.

No Virulina has not been tested in pregnancy hence is not advisable to use during pregnancy.

Yes it is safe to be consumed by all of us.For the following individuals we advise not take Virulina Patients suffering from severe multi-system symptoms which may or may not be compatible with advanced Covid-19 symptoms and patients with acute or severe chronic diseases such as active cancer.Patients having acute hypoxic respiratory failure Patients who requires Intensive care unit (ICU) care for management of ongoing clinical status. Patients with severe infection, for whom need may arise for invasive or non-invasive ventilator support Inability to intake or tolerate oral medication Category 6 or 5 based on modified 7-category ordinal scale of clinical status. Clinical prognostic non-survival, palliative care, and have no response to supportive treatment within three hours of admission.

Yes Product Virulina is safe to be consumed and patient would really be benefitted as it would help to overcome feverand also other symptoms associated with it.

Our Partners

We have innovative herbal products which have gone through stringent testing be it toxicity, In Vivo, In Vitro etc

Corporate Address
3rd Floor, A-304, Bonanza, Sahar Plaza Complex, Andheri – Kurla Road, J. B. Nagar, Andheri, East Mumbai, Mumbai Suburban, Maharashtra: 400059

This will close in 0 seconds